Complement activation and cytokine response by BioProtein, a bacterial single cell protein
Open Access
- 7 February 2007
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 148 (1), 146-152
- https://doi.org/10.1111/j.1365-2249.2007.03339.x
Abstract
The bacterial single cell protein (BSCP), BioProtein, is dried bacterial mass derived from fermentation of the gram negative bacteria Methylococcus capsulatus, used for animal and fish feed. Workers in this industry suffer frequently from pulmonary and systemic symptoms which may be induced by an inflammatory reaction. The aim of the present study was to examine the effect of BSCP on inflammation in vitro as evaluated by complement activation and cytokine production. Human serum was incubated with BSCP and complement activation products specific for all pathways were detected by enzyme-linked immunosorbent assay (ELISA). Human whole blood anti-coagulated with lepirudin was incubated with BSCP and a panel of 27 biological mediators was measured using multiplex technology. BSCP induced a dose-dependent complement activation as revealed by a pronounced increase in alternative and terminal pathway activation (fivefold and 20-fold, respectively) at doses from 1 µg BSCP/ml serum and a similar, but less extensive (two- to fourfold) increase in activation of the lectin and classical pathways at doses from 100 and 1000 µg BSCP/ml serum, respectively. Similarly, BSCP induced a dose-dependent production of a number of cytokines, chemokines and growth factors in human whole blood. At doses as low as 0·05–0·5 µg BSCP/ml blood a substantial increase was seen for tumour necrosis factor (TNF)-α, interleukin (IL)-1-β, IL-6, interferon (IFN)-γ, IL-8, monocyte chemoattractant protein (MCP)-1, macrophage inflammatory protein (MIP)-1α, MIP-1β, IL-4, IL-9, IL-17, IL-1Ra, granulocyte–colony-stimulating factor (G-CSF) and vascular endothelial growth factor (VEGF). Thus, BSCP induced a substantial activation of all three initial complement pathways as well as a pronounced cytokine response in vitro, indicating a potent inflammatory property of this agent.Keywords
This publication has 27 references indexed in Scilit:
- The IL-23/IL-17 axis in inflammationJCI Insight, 2006
- Gene expression profiles of peripheral blood leukocytes after endotoxin challenge in humansPhysiological Genomics, 2006
- Short term changes in lung function, leukocytosis in blood, and lachrymal fluid among bacterial single cell protein workers after an episode with high exposure to endotoxinsOccupational and Environmental Medicine, 2005
- Phagocytosis of Apoptotic Neutrophils Regulates Granulopoiesis via IL-23 and IL-17Immunity, 2005
- The oral immunogenicity of BioProtein, a bacterial single-cell protein, is affected by its particulate natureBritish Journal of Nutrition, 2003
- Immunotoxicity of nucleic acid reduced BioProtein—a bacterial derived single cell protein—in Wistar ratsToxicology, 2002
- Redundancy or cell‐type‐specific regulation? Tumour necrosis factor in alveolar macrophages and mast cellsImmunology, 2000
- INTERLEUKIN-1 RECEPTOR ANTAGONIST: Role in BiologyAnnual Review of Immunology, 1998
- Complement activation in septic baboons detected by neoepitope-specific assays for C3b/iC3b/C3c, C5a and the terminal C5b-9 complement complex (TCC)Clinical and Experimental Immunology, 1993
- Separation of self from non-self in the complement systemImmunology Today, 1987